Altitude and Prognosis After PCI: A Propensity Score-matched Analysis

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Aug 2

PMID 39091961

Authors

Si-Yu Yan

Li-Hong Ma

Wei-Xian Yang

Affiliations

Soon will be listed here.

Abstract

Background: The impact of altitude on the prognosis of patients with coronary artery disease (CAD) after percutaneous coronary intervention (PCI) deserves further discussion and research.

Methods: We conducted a post hoc analysis of a prospective observational study involving 5453 patients post-PCI, divided into medium-altitude and low-altitude groups. To control for confounding factors, propensity score matching was employed to pair patients with similar baseline characteristics between the two groups. The impact of altitude factors on patients' prognosis post-PCI was examined through endpoint events over a 2-year follow-up period.

Results: During the 2-year follow-up, patients at medium altitude exhibited a lower risk of MACE (including cardiovascular mortality, myocardial infarction, revascularization, and stroke) compared to those at low altitude (1196 versus 1196 patients [medium-altitude versus low-altitude, respectively]; hazard ratio [HR], 0.781 [95 % CI, 0.629-0.969]; P = 0.025) during 2-year follow-up. Even after excluding stroke, a significant difference in heart-related adverse events (HRAE) persisted between the two groups (HR, 0.794; 95 % CI, 0.636-0.991; P = 0.042). The incidences of individual MACE components were not significantly different between the two groups.

Conclusions: Patients post-PCI residing at medium altitude exhibited a lower risk of 2-year MACE compared to those at low altitude. Further research is necessary to provide more robust evidence.

References

Burtscher J, Millet G, Burtscher M . Does living at moderate altitudes in Austria affect mortality rates of various causes? An ecological study. BMJ Open. 2021; 11(6):e048520. PMC: 8183194. DOI: 10.1136/bmjopen-2020-048520. View

Lucitti J, Sealock R, Buckley B, Zhang H, Xiao L, Dudley A . Variants of Rab GTPase-Effector Binding Protein-2 Cause Variation in the Collateral Circulation and Severity of Stroke. Stroke. 2016; 47(12):3022-3031. PMC: 5134893. DOI: 10.1161/STROKEAHA.116.014160. View

Riggs D, Yeager R, Bhatnagar A . Defining the Human Envirome: An Omics Approach for Assessing the Environmental Risk of Cardiovascular Disease. Circ Res. 2018; 122(9):1259-1275. PMC: 6398443. DOI: 10.1161/CIRCRESAHA.117.311230. View

Pu H, Li J, Wang P, Cui L, Wang H . The death of the circulatory system diseases in China: provincial socioeconomic and environmental perspective. Environ Sci Pollut Res Int. 2017; 24(11):10381-10390. DOI: 10.1007/s11356-017-8677-2. View

Donegani E, Hillebrandt D, Windsor J, Gieseler U, Rodway G, Schoffl V . Pre-existing cardiovascular conditions and high altitude travel. Consensus statement of the Medical Commission of the Union Internationale des Associations d'Alpinisme (UIAA MedCom) Travel Medicine and Infectious Disease. Travel Med Infect Dis. 2014; 12(3):237-52. DOI: 10.1016/j.tmaid.2014.02.004. View

de Leon A, Almeida Gonzalez D, Perez Mendez L, Aguirre-Jaime A, Rodriguez Perez M, Coello S . Leptin and altitude in the cardiovascular diseases. Obes Res. 2004; 12(9):1492-8. DOI: 10.1038/oby.2004.186. View

Ma Y, Zhu L, Ma Z, Gao Z, Wei Y, Shen Y . Distinguishing feature of gut microbiota in Tibetan highland coronary artery disease patients and its link with diet. Sci Rep. 2021; 11(1):18486. PMC: 8445913. DOI: 10.1038/s41598-021-98075-9. View

Faeh D, Gutzwiller F, Bopp M . Lower mortality from coronary heart disease and stroke at higher altitudes in Switzerland. Circulation. 2009; 120(6):495-501. DOI: 10.1161/CIRCULATIONAHA.108.819250. View

Tsao C, Aday A, Almarzooq Z, Alonso A, Beaton A, Bittencourt M . Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022; 145(8):e153-e639. DOI: 10.1161/CIR.0000000000001052. View

10.

Faeh D, Moser A, Panczak R, Bopp M, Roosli M, Spoerri A . Independent at heart: persistent association of altitude with ischaemic heart disease mortality after consideration of climate, topography and built environment. J Epidemiol Community Health. 2016; 70(8):798-806. DOI: 10.1136/jech-2015-206210. View

11.

VOORS A, Johnson W . Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States. J Chronic Dis. 1979; 32(1-2):157-62. DOI: 10.1016/0021-9681(79)90044-4. View

12.

Scarborough P, Allender S, Rayner M, Goldacre M . Contribution of climate and air pollution to variation in coronary heart disease mortality rates in England. PLoS One. 2012; 7(3):e32787. PMC: 3299689. DOI: 10.1371/journal.pone.0032787. View

13.

Khattar N, Sumardi F, Zemmar A, Liang Q, Li H, Xing Y . Cerebral Venous Thrombosis at High Altitude: A Retrospective Cohort of Twenty-one Consecutive Patients. Cureus. 2019; 11(6):e4940. PMC: 6697453. DOI: 10.7759/cureus.4940. View

14.

Richalet J, Hermand E, Lhuissier F . Cardiovascular physiology and pathophysiology at high altitude. Nat Rev Cardiol. 2023; 21(2):75-88. DOI: 10.1038/s41569-023-00924-9. View

15.

Macovei L, Macovei C, Macovei D . Coronary Syndromes and High-Altitude Exposure-A Comprehensive Review. Diagnostics (Basel). 2023; 13(7). PMC: 10092947. DOI: 10.3390/diagnostics13071317. View

16.

Rimoldi S, Sartori C, Seiler C, Delacretaz E, Mattle H, Scherrer U . High-altitude exposure in patients with cardiovascular disease: risk assessment and practical recommendations. Prog Cardiovasc Dis. 2010; 52(6):512-24. DOI: 10.1016/j.pcad.2010.03.005. View

17.

Zhang H, Faber J . De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells. J Mol Cell Cardiol. 2015; 87:4-16. PMC: 4637183. DOI: 10.1016/j.yjmcc.2015.07.020. View

18.

Krause R, Buhring M, Hopfenmuller W, Holick M, Sharma A . Ultraviolet B and blood pressure. Lancet. 1998; 352(9129):709-10. DOI: 10.1016/S0140-6736(05)60827-6. View

19.

Burtscher M, Millet G, Klimont J, Burtscher J . Differences in the prevalence of physical activity and cardiovascular risk factors between people living at low (<1,001 m) compared to moderate (1,001-2,000 m) altitude. AIMS Public Health. 2021; 8(4):624-635. PMC: 8568593. DOI: 10.3934/publichealth.2021050. View

20.

Coello S, Cabrera de Leon A, Bosa Ojeda F, Perez Mendez L, Diaz Gonzalez L . High density lipoprotein cholesterol increases with living altitude. Int J Epidemiol. 2000; 29(1):65-70. DOI: 10.1093/ije/29.1.65. View